Evidence map›Paper›PMID 38776486›Full record

ArticleJCO oncology practice2025

Primary Care Provider Visits Among Cancer Survivors 5-7 Years Postdiagnosis.

Sarah A Birken, Alexandra G Peluso, David I Shalowitz, Scott Isom, Cheyenne R Wagi, Aliza Randazzo, Derek Falk, Carla Strom, Ronny Bell, Kathryn E Weaver

Abstract read
In one paragraph

Article in JCO oncology practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Multidomain predictors of long-term work disability in late survivorship after head and neck cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Exploring disparities in healthcare utilization, cancer care experience, and beliefs about cancer among asian and hispanic cancer survivors.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sarah A BirkenDepartment of Implementation Science, Wake Forest School of Medicine, Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC.ORCID 0000-0002-0591-4800
Alexandra G PelusoDepartment of Implementation Science, Wake Forest School of Medicine, Winston-Salem, NC.
David I ShalowitzWest Michigan Cancer Center, Kalamazoo, MI.ORCID 0000-0002-5189-4687
Scott IsomDepartment of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC.
Cheyenne R WagiDepartment of Implementation Science, Wake Forest University School of Medicine, Winston-Salem, NC.
Aliza RandazzoDepartment of Implementation Science, Wake Forest University School of Medicine, Winston-Salem, NC.
Derek FalkDepartment of Population and Quantitative Health Science, Case Western Reserve University School of Medicine, Cleveland, OH.ORCID 0000-0001-5929-8874
Carla StromOffice of Cancer Health Equity, Comprehensive Cancer Center, Atrium Health Wake Forest Baptist, Winston-Salem, NC.
Ronny BellDivision of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, UNC Chapel Hill, Chapel Hill, NC.ORCID 0000-0001-8512-2565
Kathryn E WeaverDepartment of Social Sciences and Health Policy, Wake Forest University School of Medicine, Winston-Salem, NC.ORCID 0000-0001-9006-4064

Funding

Tumor Tissue CoreP30CA012197 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ruben A. Mesa · 1985 to 2026
$55.4M
Consumer-based meditation app, Calm, for treatment of sleep disturbance in hematological cancer patientsR01CA262041 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Jennifer Lynne Huberty, Ruben A. Mesa · 2022 to 2026
$2.8M
NCI NIH HHS P30 CA012197NCI NIH HHS R01 CA262041
6 · The paper itself

Abstract

purposeCancer survivors experience better outcomes when primary care providers (PCPs) are engaged in their care. Nearly all survivors have a PCP engaged in their care in the initial 5 years postdiagnosis, but little is known about sustained PCP engagement. We assessed PCP engagement in survivors' care 5-7 years postdiagnosis and characterized survivors most vulnerable to loss to PCP follow-up.

methodsWe linked electronic health record ambulatory care and cancer registry data from an National Cancer Institute-Designated Comprehensive Cancer Center to identify eligible survivors (≥18 years; diagnosed with breast, colorectal, or uterine cancer; had an in-network PCP). We used multiple logistic regression to assess associations between survivor demographics, clinical factors, and health care utilization and odds of sustained PCP engagement.

resultsIn 5-7 years postdiagnosis, PCPs were engaged in care for 43% of survivors. Survivors with sustained PCP-engagement were on average 4.6 years older than those without (

conclusionSustained PCP engagement is endorsed as critical by survivors, PCPs, and oncologists. We found most survivors were lost to PCP follow-up 5-7 years postdiagnosis. Our study is among the first to contribute empirical evidence of survivors being lost in transition. Findings from this study demonstrate the need to bridge gaps in long-term care for cancer survivors.

Indexed as

Cancer SurvivorsNeoplasmsPrimary Health CareAdultAgedFemaleHumansMaleMiddle Aged

Identifiers

PMID38776486
PMCPMC11582079

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.